Cancer and the Critical Role of Gut Health Assessment
Updated: 6 days ago

The connection between the gut microbiome and cancer is an area of rapidly growing research. I previously wrote about How the Microbiome Influences the Development and Progression of Cancer, discussing the microbiome's relationship with immune regulation, inflammation, metabolism, nutrient absorption, treatment response, and gene expression.
New research from Mayo Clinic, published on September 29, 2026, adds to this growing body of evidence and reinforces why I believe gut health deserves greater attention in cancer care and survivorship.
What Is the Connection Between the Microbiome and Cancer?
The microbiome is not simply a collection of bacteria living in the digestive tract. It’s a complex ecosystem that communicates with the immune system and influences inflammation, metabolism, nutrient availability, hormone metabolism, and other processes throughout the body. When this ecosystem becomes disrupted, a condition known as dysbiosis, changes may occur in immune regulation, inflammatory signaling, intestinal barrier function, and microbial metabolism.
These relationships are particularly relevant to cancer because the immune system, inflammation, metabolism, and cellular signaling all play important roles in cancer development and biology.
As I discussed in my previous article, certain gut microorganisms also produce metabolites such as short chain fatty acids that can influence intestinal and immune function. Other microorganisms can affect the metabolism of hormones and other compounds. Therefore, the microbiome may also influence how patients respond to certain cancer treatments and how they experience treatment related side effects.
New Mayo Clinic Research
A recent Mayo Clinic study published in Cell analyzed stool samples from 1,364 patients with cancer across different cancer types, stages, and treatments, along with samples from 287 individuals without cancer. Researchers identified 341 bacterial species associated with five cancer groups. They also found distinct microbiome patterns in people diagnosed with colorectal and breast cancer at age 50 or younger.
In addition, the researchers found associations between specific gut bacteria and survival in several cancer types and identified a pretreatment microbiome signal associated with diarrhea in patients receiving 5 fluorouracil chemotherapy.
Read the full Mayo Clinic report, Distinct gut microbiome patterns found in 5 cancer groups and in early onset cancers.
Why I Assess Gut Health After Cancer Treatment
Cancer treatment can significantly affect the gastrointestinal environment. Chemotherapy, radiation, antibiotics, medications, surgery, changes in diet, stress, and other factors can alter the composition and function of the microbiome. Some patients develop obvious digestive symptoms such as diarrhea, constipation, bloating, or abdominal discomfort. Others may have changes in their gastrointestinal environment without significant symptoms.
This is one reason I often consider a comprehensive gastrointestinal stool analysis after conventional cancer treatment. My goal is not to determine whether a patient has digestive symptoms but to better understand the environment in which the patient's microbiome is functioning.
I also want to identify any underlying gastrointestinal abnormalities that may have been present leading up to or around the time of a cancer diagnosis. Understanding these factors may help identify areas that can be addressed to support digestive health, immune function, nutrition, and overall survivorship.
What Does a Comprehensive Stool Analysis Evaluate?
The comprehensive stool analysis I use in clinical practice evaluates more than 100 markers across multiple areas of gastrointestinal health. The laboratory describes the profile as assessing more than 127 markers across 15 categories, including microbiota composition, pathogens, fungi and yeast, parasites, short chain fatty acids, gastrointestinal functional markers, and both PCR and culture based testing. Rather than focusing on one microorganism, I look at several interconnected areas.
Microbiome Composition
The analysis evaluates major bacterial groups and specific beneficial microorganisms, including species of Bifidobacterium, Lactobacillus, Akkermansia muciniphila, and Faecalibacterium prausnitzii. The goal is not simply to determine whether a particular "good" bacterium is present. I am interested in the overall microbial balance and how the different organisms interact.
Short Chain Fatty Acids
The test measures short chain fatty acids including butyrate, acetate, propionate, and valerate. These compounds are produced by gut microorganisms and provide important information about microbial activity, intestinal metabolism, and the integrity of the mucosal lining.
Opportunistic Organisms, Pathogens, Fungi, and Parasites
The analysis evaluates a broad range of potentially problematic organisms, including opportunistic bacteria, bacterial pathogens, viruses, fungi and yeast, and parasites. It also includes assessment of H. pylori and several associated virulence factors.
Gastrointestinal Function
The test also evaluates markers that provide information about the intestinal environment and digestive function, including:
• Calprotectin, associated with intestinal inflammation
• Pancreatic elastase, related to pancreatic digestive function
• Secretory IgA, an important component of mucosal immune defense
• Zonulin, associated with intestinal barrier regulation
• Beta glucuronidase, an enzyme produced by certain gut bacteria
• Steatocrit, related to fat digestion and absorption
• Alpha transglutaminase IgA
• Stool pH
These markers can become particularly meaningful when interpreted together with the microbiome findings.
Why Looking at the Whole Picture Matters
A comprehensive assessment allows me to look at the relationships between microbial composition, microbial metabolites, intestinal inflammation, digestive function, and immune activity rather than viewing each result independently. For example, reduced levels of certain beneficial microorganisms may have a different clinical significance when accompanied by altered short chain fatty acids or evidence of intestinal inflammation. This is why I do not approach microbiome testing as simply looking for "good bacteria" and "bad bacteria." I am looking at the ecosystem.
PCR and Culture Provide Complementary Information
The testing approach I use incorporates both PCR and culture. PCR can detect microbial genetic material, while culture attempts to grow viable organisms and identify them. Using both methods can provide complementary information when evaluating certain microbial findings. The laboratory also provides antimicrobial sensitivity information for organisms identified through culture. This can help inform a more individualized approach when an abnormal finding requires treatment.
The Value of Testing the Microbiome
For me, the value of comprehensive testing is in helping answer a larger question:
“What does this patient's gastrointestinal system need to function at its best, knowing that our gut plays such a crucial role in our immunity?”
Depending on the findings, an individualized plan may include nutritional changes, dietary fiber, targeted probiotics or prebiotics, botanical medicine, digestive support, or treatment of specific gastrointestinal abnormalities.
Looking More Closely at the Microbiome
We are still learning how complex the relationship between the microbiome and cancer truly is. The recent Mayo Clinic research adds important evidence that specific microbial patterns may be associated with different cancers, survival, and certain treatment related side effects.
That is why I believe comprehensive gut health assessment can be an important part of integrative oncology and survivorship care.
Coming Next
In my next article, I’ll share more about the clinical findings I see on comprehensive GI stool testing in my patients diagnosed with cancer and explain how I interpret common findings within the broader context of integrative oncology and survivorship.
To learn more about integrative approaches to cancer care, explore the educational resources available here at Integrative Oncology Specialist.




